jmbeck@reedsmith.com

{{ disclaimer.HeaderText }}

{{ disclaimer.BodyCopy }}
James joined Reed Smith's Life Sciences Health Industries Group in the spring of 2012.

Awards & Recognition

  • Selected as a Top Author in the Product Liability and Medical Device Industry categories for the JD Supra Readers Choice Awards, 2017 
  • Selected as one of JD Supra’s Top Authors for the JD Supra Readers' Choice Awards, 2016
  • Best Newsletter Award (American Bar Association, Section of Litigation), 2015
  • Pennsylvania Defense Institute's Distinguished Defense Counsel Award, 2015
  • Listed in The International Who's Who of Life Sciences – Product Liability Lawyers
  • John T. Raleigh Lifetime Achievement Award (Product Liability Advisory Council), 2011
  • American Bar Association Top 100 Legal Blogs, 2013, 2012, 2011, 2010, 2009

Notable Quotes

  • 1 March 2017 "Missouri Could Be Less Open to Out-of-State Plaintiffs" Bloomberg BNA
  • 30 January 2017 "Bristol-Meyers Case Could Have Wide Effect, Attorneys Say" Bloomberg BNA
  • 27 January 2017 "Ex-Accutane User's Time Limit Win May Draw Drug Suits To NJ" Law360
  • 25 January 2017 "James Beck Joins 3D Printing Protection Team" The American Law Institute
  • 25 January 2017 "Law firm Reed Smith establishes team to protect 3D printer users from lawsuits" 3Ders.org
  • 24 January 2017 " Reed Smith firm opens up new field: Protecting 3D printing from lawsuits" Philadelphia Inquirer
  • 20 January 2017 "Defense Bar Sees Jury Instructions Win in Latest Post-'Tincher' Ruling" The Legal Intelligencer
  • 28 September 2016 "3-D Printing Leaps Ahead of Product Liability Law" Bloomberg BNA
  • 2 September 2016 "Calif. Mass-Tort Ruling Not Seen Likely to Empty Pa. Dockets" The Legal Intelligencer
  • 1 September 2016 "Attorneys Agree Ban on Citing Nonprecedential Opinions Is a Hurdle" The Legal Intelligencer
  • 30 August 2016 "Plavix Ruling Cements Calif. As Center For Mass Torts" Law360
  • 15 August 2016 "Honda Says Plaintiffs Went Off Limits in Argument Over Crashworthiness Jury Charge" The Legal Intelligencer
  • 2 August 2016 "Appeals Court Overturn Philly Jury's $27M Award Over Knee Injury" Penn Record
  • 25 July 2016 "Out-of-State Pharma Filings Dip as Phila. Mass Torts Remain Steady" The Legal Intelligencer
  • 7 June 2016 "3-D Printing Set to Disrupt Products Liability Law" Pittsburgh Post-Gazette
  • 24 May 2016 "3-D Printing Set to Disrupt Products Liability Law" The Legal Intelligencer
  • 29 April 2016 "Lawyers Benefit Most From No-Injury Class Actions, Study Says" Law.com
  • 5 April 2016 "Industry To FDA: "Emerging Signals" May Do More Harm Than Good" Med Device Online
  • 9 February 2016 "Products Liability an 'Unnerving New World' Since 'Tincher'" Pennsylvania Law Weekly
  • 11 January 2016 "FDA Lawyers Question New Medical Device Safety Policy" Politico Prescription Pulse
  • 15 December 2015 "FDA in pain drug restriction U-turn" Financial Times
  • 23 November 2015 "Keeping the Jurisdictional Toothpaste in the Tube: "General Jurisdiction By Consent" After Daimler AG v. Bauman" Washington Legal Foundation
  • 17 November 2015 "Litigants May Test High Court After Turnover" The Legal Intelligencer
  • 16 November 2015 "Judge Notes 'Considerable Confusion' in Post-'Tincher' Ruling" The Legal Intelligencer
  • 13 November 2015 "Liability and Legal Issues May Derail the Future of 3D Printed Medication" 3DPrint.com
  • 10 November 2015 "Attorneys Note Legal Issues for 3D Printing of Drugs" Bloomberg BNA
  • 2 November 2015 "Blogging on the Run" American Lawyer
  • 16 October 2015 "Cross-Court Zoloft Rulings Highlight Different Standards" The Legal Intelligencer
  • 1 September 2015 "Possible FDA/Amarin Off-Label Deal; Rule Tweaks Ahead?" SCRIP Intelligence
  • 17 August 2015 "What to expect in wake of the Amarin ruling: more truthful off-label talk from pharma" Medical Marketing & Media
  • 14 August 2015 "Drug minnow Amarin downs FDA in constitutional battle" The Irish Times
  • 10 August 2015 "Amarin Case Could Unleash a Flood of Off-Label Promos" FiercePharmaMarketing
  • 10 August 2015 "FDA Loses Case Against Drug Marketing" Infinite Path
  • 9 August 2015 "Foreign Drug Manufacturer Allowed to Use Off-Label Marketing" Morning Ticker
  • 9 August 2015 "Irish Drug Manufacturer Amarin Pharma Inc Gets Green Light From US FDA For Drug Vascepa" Pioneer News
  • 8 August 2015 "Court Ruling Could Loosen Rules on Drug Marketing" Forex Report Daily
  • 8 August 2015 "Want To Promote Off-Label? Pick Your Battlefield" SCRIP Intelligence
  • 7 August 2015 "Amarin wins early victory against FDA in 'free speech' case over drug promotion" U.S. News & World Report
  • 7 August 2015 "5 Questions After Amarin's Off-Label Marketing Triumph" Law360
  • 13 July 2015 "Mass Tort Inventory Stays High in Wake of Program Changes" The Legal Intelligencer
  • 23 February 2015 "Claims Preempted in Branded Drug Suit; Maker Couldn't Unilaterally Change Label" Bloomberg BNA
  • 20 January 2015 "Citing Tincher, Lackawanna Judge Upholds $5.9M Verdict" The Legal Intelligencer
  • 26 September 2014 "Preemption Trend Favors Pharma in Generic Reglan Fight" Law360
  • 26 August 2014 "Restatement Rift Remains as Bar Awaits Tincher Ruling" The Legal Intelligencer
  • 18 August 2014 "Alabama Court Bucks Trend, Says Generic Patient Can Sue Pfizer" Litigation Daily
  • 9 July 2014 "The Biggest Product Liability Cases of 2014" Law360

Credentials

  • Princeton University, 1978, B.A., cum laude
  • University of Pennsylvania Law School, 1982, J.D.

  • Pennsylvania

  • U.S. District Court - Eastern District of Pennsylvania
  • U.S. Supreme Court
  • U.S. Court of Appeals - Third Circuit

  • Member – American Law Institute, 2005
  • ABA Outstanding Subcommittee Chair, 2002-04, 2003-04, 2004-05, 2009-10